Lemaitre Vascular (LMAT) Misses Q1 EPS by 2c, Raises FY 2018 EPS Guidance, Lowers FY 2018 Rev Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Lemaitre Vascular (LMAT) Misses Q1 EPS by 2c, Raises FY 2018 EPS Guidance, Lowers FY 2018 Rev Guidance

Benchmark Upgrades LeMaitre Vascular (LMAT) to Buy; 'Sell-Off Overdone; 2019 Outlook Should Improve'

April 26, 2018 1:32 PM EDT

Benchmark upgraded LeMaitre Vascular (NASDAQ: LMAT) from Hold to Buy.

For an analyst ratings summary and ratings history on LeMaitre Vascular click here. For more ratings news on LeMaitre Vascular click here.

Shares of LeMaitre Vascular closed at $39.01 yesterday.

... More

Stifel Downgrades LeMaitre Vascular (LMAT) to Hold

April 26, 2018 3:53 AM EDT

Stifel downgraded LeMaitre Vascular (NASDAQ: LMAT) from Buy to Hold with a price target of $34.00 (from $40.00).

Analyst Rick Wise cites visibility for stepping ot the sideline as he struggles to articulate the company's top-line and operating income growth drivers.

For an analyst... More